A Trojan horse for thirsty tumours

Elie Dolgin • July 11, 2024

Joining a drug candidate to a protein that malignant cells naturally take up allowed one firm to come up with a potent anti-cancer therapy.

‘Connectoids’ use microfluid channels to recapitulate and study neural connections.
By Elie Dolgin May 14, 2025
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Picture of scientist handling mRNA, Robert F. Kennedy Jr. and vaccine protesters.
By Elie Dolgin May 9, 2025
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.